Literature DB >> 21351156

The origins of glioma: E Pluribus Unum?

F A Siebzehnrubl1, B A Reynolds, A Vescovi, D A Steindler, L P Deleyrolle.   

Abstract

Malignant glioma is among of the most devastating, and least curable, types of cancer. Since the re-emergence of the cancer stem cell hypothesis, much progress has been made towards elucidating the cellular origin of these tumors. The hypothesis that tumors are hierarchically organized, with a cancer stem cell at the top that shares defining features with somatic stem cells and provides therapeutic refractoriness properties, has put adult stem cells into the limelight as prime suspect for malignant glioma. Much confusion still exists, though, as to the particular cell type and processes that lead to oncogenic transformation. In this review, we will discuss recent developments and novel hypotheses regarding the origin of malignant gliomas, especially glioblastoma. In particular, we argue that glioblastoma is the result of different pathways originating in multiple sources that all ultimately converge in the same disease. Further attention is devoted to potential scenarios leading to transformation of different stem/progenitor cell types of the brain, and the probability and relevance of these scenarios for malignant tumorigenesis.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21351156     DOI: 10.1002/glia.21143

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  37 in total

Review 1.  Unique biology of gliomas: challenges and opportunities.

Authors:  Stacey Watkins; Harald Sontheimer
Journal:  Trends Neurosci       Date:  2012-06-08       Impact factor: 13.837

Review 2.  The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.

Authors:  Manfred Westphal; Katrin Lamszus
Journal:  Nat Rev Neurosci       Date:  2011-08-03       Impact factor: 34.870

Review 3.  On the origin of cancer metastasis.

Authors:  Thomas N Seyfried; Leanne C Huysentruyt
Journal:  Crit Rev Oncog       Date:  2013

4.  Glypican 1 stimulates S phase entry and DNA replication in human glioma cells and normal astrocytes.

Authors:  Dianhua Qiao; Kristy Meyer; Andreas Friedl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

Review 5.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

Review 6.  The Role of Metabolic Plasticity in Blood and Brain Stem Cell Pathophysiology.

Authors:  Catherine J Libby; Jonathan McConathy; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

7.  Bex2 is critical for migration and invasion in malignant glioma cells.

Authors:  Xiuping Zhou; Xuebin Xu; Qingming Meng; Jinxia Hu; Tongle Zhi; Qiong Shi; Rutong Yu
Journal:  J Mol Neurosci       Date:  2012-08-03       Impact factor: 3.444

8.  Immunohistochemical analyses point to epidermal origin of human Merkel cells.

Authors:  Thomas Tilling; Ewa Wladykowski; Antonio Virgilio Failla; Pia Houdek; Johanna M Brandner; Ingrid Moll
Journal:  Histochem Cell Biol       Date:  2013-11-30       Impact factor: 4.304

9.  Detection of primary cilia in human glioblastoma.

Authors:  Matthew R Sarkisian; Dorit Siebzehnrubl; Lan Hoang-Minh; Loic Deleyrolle; Daniel J Silver; Florian A Siebzehnrubl; Sarah M Guadiana; Gayathri Srivinasan; Susan Semple-Rowland; Jeffrey K Harrison; Dennis A Steindler; Brent A Reynolds
Journal:  J Neurooncol       Date:  2014-02-09       Impact factor: 4.130

10.  MicroRNA-153 is tumor suppressive in glioblastoma stem cells.

Authors:  Shiguang Zhao; Yifan Deng; Yaohua Liu; Xin Chen; Guang Yang; Yulong Mu; Daming Zhang; Jianhao Kang; Zhaoli Wu
Journal:  Mol Biol Rep       Date:  2013-02-11       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.